Lenmeldy (atidarsagene autotemcel) is officially the world’s most expensive drug. On the day they received approval, the company behind the drug set the price at a staggering $4.25 million.
Orchard Therapeutics has tasked Robin Kenselaar with accelerating growth of Lenmeldy, the world’s most expensive drug, promoting him to chief commercial officer after a year in which sales of ...